Neuren Pharmaceuticals 관리
관리 기준 확인 3/4
Neuren Pharmaceuticals CEO는 Jon Pilcher, May2020 에 임명되었습니다 의 임기는 4.5 년입니다. 총 연간 보상은 A$ 1.36M, 40.2% 로 구성됩니다. 40.2% 급여 및 59.8% 보너스(회사 주식 및 옵션 포함). 는 A$ 6.59M 가치에 해당하는 회사 주식의 0.31% 직접 소유합니다. 6.59M. 경영진과 이사회의 평균 재임 기간은 각각 4.4 년과 6.3 년입니다.
주요 정보
Jon Pilcher
최고 경영자
AU$1.4m
총 보상
| CEO 급여 비율 | 40.2% |
| CEO 임기 | 4.5yrs |
| CEO 소유권 | 0.3% |
| 경영진 평균 재임 기간 | 4.4yrs |
| 이사회 평균 재임 기간 | 6.3yrs |
최근 관리 업데이트
Recent updates
New Forecasts: Here's What Analysts Think The Future Holds For Neuren Pharmaceuticals Limited (ASX:NEU)
Nov 11
Neuren Pharmaceuticals Limited's (ASX:NEU) Shares Climb 26% But Its Business Is Yet to Catch Up
Nov 08Calculating The Intrinsic Value Of Neuren Pharmaceuticals Limited (ASX:NEU)
Oct 24Neuren Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models
Aug 29Pinning Down Neuren Pharmaceuticals Limited's (ASX:NEU) P/S Is Difficult Right Now
Aug 14Here's Why We Think Neuren Pharmaceuticals (ASX:NEU) Might Deserve Your Attention Today
May 31Getting In Cheap On Neuren Pharmaceuticals Limited (ASX:NEU) Is Unlikely
May 03An Intrinsic Calculation For Neuren Pharmaceuticals Limited (ASX:NEU) Suggests It's 41% Undervalued
Apr 01Forecast: Analysts Think Neuren Pharmaceuticals Limited's (ASX:NEU) Business Prospects Have Improved Drastically
Mar 05Here's Why Neuren Pharmaceuticals (ASX:NEU) Has Caught The Eye Of Investors
Mar 02Neuren Pharmaceuticals Limited's (ASX:NEU) 51% Jump Shows Its Popularity With Investors
Dec 18Need To Know: Analysts Are Much More Bullish On Neuren Pharmaceuticals Limited (ASX:NEU) Revenues
Sep 02Calculating The Fair Value Of Neuren Pharmaceuticals Limited (ASX:NEU)
Aug 31This Just In: Analysts Are Boosting Their Neuren Pharmaceuticals Limited (ASX:NEU) Outlook for This Year
Mar 03Neuren Pharmaceuticals (ASX:NEU) Is In A Strong Position To Grow Its Business
Jan 07We Think Neuren Pharmaceuticals (ASX:NEU) Can Easily Afford To Drive Business Growth
Sep 06Companies Like Neuren Pharmaceuticals (ASX:NEU) Can Afford To Invest In Growth
May 31We're Not Worried About Neuren Pharmaceuticals' (ASX:NEU) Cash Burn
Feb 03Here's Why We're Not At All Concerned With Neuren Pharmaceuticals' (ASX:NEU) Cash Burn Situation
Aug 06We Think Neuren Pharmaceuticals (ASX:NEU) Can Easily Afford To Drive Business Growth
May 05Independent Non-Executive Chairman Patrick Donald Davies Just Bought 21% More Shares In Neuren Pharmaceuticals Limited (ASX:NEU)
Feb 19Have Insiders Been Selling Neuren Pharmaceuticals Limited (ASX:NEU) Shares This Year?
Jan 04
CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | AU$117m |
| Mar 31 2024 | n/a | n/a | AU$137m |
| Dec 31 2023 | AU$1m | AU$549k | AU$157m |
| Sep 30 2023 | n/a | n/a | AU$106m |
| Jun 30 2023 | n/a | n/a | AU$55m |
| Mar 31 2023 | n/a | n/a | AU$28m |
| Dec 31 2022 | AU$546k | AU$396k | AU$184k |
| Sep 30 2022 | n/a | n/a | -AU$3m |
| Jun 30 2022 | n/a | n/a | -AU$7m |
| Mar 31 2022 | n/a | n/a | -AU$7m |
| Dec 31 2021 | AU$432k | AU$203k | -AU$8m |
보상 대 시장: Jon 의 총 보상 ($USD 890.72K ) Australian 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 1.47M ).
보상과 수익: Jon 의 보상은 지난 1년 동안 20% 이상 증가했습니다.
CEO
Jon Pilcher
4.5yrs
테뉴어
AU$1,364,404
보상
Mr. Jonathan Charles Pilcher, also known as Jon, BSc (Hons), ACA, FCA serves as Managing Director & Executive Director at Neuren Pharmaceuticals Limited since June 14, 2021. He had been a Company Secretary...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO, MD & Executive Director | 4.5yrs | AU$1.36m | 0.31% A$ 6.6m | |
| CFO & Company Secretary | 4.3yrs | 데이터 없음 | 데이터 없음 | |
| Chief Science Officer | 20.8yrs | 데이터 없음 | 데이터 없음 | |
| Vice President of Corporate Development | no data | 데이터 없음 | 데이터 없음 | |
| Chief Medical Officer | 2.3yrs | 데이터 없음 | 데이터 없음 |
4.4yrs
평균 재임 기간
경험이 풍부한 관리: NEU 의 관리팀은 경험 ( 4.4 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO, MD & Executive Director | 3.4yrs | AU$1.36m | 0.31% A$ 6.6m | |
| Independent Non-Executive Director | 6.3yrs | AU$75.00k | 0.023% A$ 496.2k | |
| Independent Non-Executive Director | 6.3yrs | AU$75.00k | 0.023% A$ 490.7k | |
| Independent Non-Executive Chairman | 6.3yrs | AU$125.00k | 0.21% A$ 4.4m | |
| Independent Non-Executive Director | 1.7yrs | AU$62.50k | 0.017% A$ 354.1k |
6.3yrs
평균 재임 기간
경험이 풍부한 이사회: NEU 의 이사회는 경험(평균 재직 기간 6.3 년)으로 간주됩니다.